This limitation determines the need for future studies incorporating both functional assays and metabolic analyses to provide a more comprehensive understanding of the mechanisms underlying SOCS3-related lipid accumulation and BBP-induced fatty liver. This evidence concerns the gene SOCS3 and Hepatic steatosis.